Trimetazidine in the prevention of contrast‐induced nephropathy after coronary procedures

OBJECTIVE: To evaluate the efficacy of trimetazidine (TMZ) in the prevention of contrast‐induced nephropathy (CIN) in patients with high serum creatinine levels undergoing coronary angiography/angioplasty. METHODS: TMZ (20 mg thrice daily) was administered orally for 72 h starting 48 h before the pr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Onbasili, Alper O, Yeniceriglu, Yavuz, Agaoglu, Pınar, Karul, Aslıhan, Tekten, Tarkan, Akar, Harun, Discigil, Guzel
Format: Artigo
Langue:Inglês
Publié: BMJ Group 2007
Sujets:
Interventional Cardiology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1955192/
https://ncbi.nlm.nih.gov/pubmed/17065180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/hrt.2006.097477
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires